These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37839675)

  • 1. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
    Sadigh S; DeAngelo DJ; Garcia JS; Hasserjian RP; Hergott CB; Lane AA; Lovitch SB; Lucas F; Luskin MR; Morgan EA; Pinkus GS; Pozdnyakova O; Rodig SJ; Shanmugam V; Tsai HK; Winer ES; Zemmour D; Kim AS
    Mod Pathol; 2024 Jan; 37(1):100352. PubMed ID: 37839675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation.
    Hamadeh F; Awadallah A; Meyerson HJ; Beck RC
    Cytometry B Clin Cytom; 2020 Jan; 98(1):43-51. PubMed ID: 30614203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients.
    Khanlari M; Yin CC; Takahashi K; Lachowiez C; Tang G; Loghavi S; Bah I; Wang W; Konoplev S; Medeiros LJ; Pemmaraju N; Khoury JD; Wang SA
    Leukemia; 2022 May; 36(5):1343-1350. PubMed ID: 35279700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis.
    Suma S; Sakata-Yanagimoto M; Nguyen TB; Hattori K; Sato T; Noguchi M; Nannya Y; Ogawa S; Watanabe R; Fujimoto M; Nakamura N; Kusakabe M; Nishikii H; Kato T; Chiba S
    Int J Hematol; 2018 Oct; 108(4):447-451. PubMed ID: 29705980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
    Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
    Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous presentation preceding acute myeloid leukemia with CD4+/CD56+ expression misdiagnosed as a blastic plasmocytoid dendritic cell neoplasm: A case report.
    Szablewski V; Costes V; Bret C; Dereure O; Yosr H; Alame M; Cacheux V
    J Cutan Pathol; 2018 Aug; 45(8):610-614. PubMed ID: 29660158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous myeloid dendritic cell dyscrasia: A cutaneous clonal monocytosis associated with chronic myeloproliferative disorders and peripheral blood monocytosis.
    Magro CM; Momtahen S; Verma S; Abraham RM; Friedman C; Nuovo GJ; Tam W
    Ann Diagn Pathol; 2016 Dec; 25():85-91. PubMed ID: 27806853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases.
    Ohgami RS; Aung PP; Gru AA; Hussaini M; Singh K; Querfeld C; Yao K; Small C; Gollapudi S; Jaye D; Wang SA; Pullarkat S; George TI
    Arch Pathol Lab Med; 2023 Jul; 147(7):837-846. PubMed ID: 36170615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
    Lim MS; Lemmert K; Enjeti A
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia.
    Song J; Li W; Bai Y; Zhou P; Niu J; Niu X; Liu Y; Liu X; Drokow EK; Sun K; Zhou H
    Ann Hematol; 2024 Feb; 103(2):463-473. PubMed ID: 38183444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
    Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
    Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
    Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH
    Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia.
    Kazama S; Yokoyama K; Ueki T; Kazumoto H; Satomi H; Sumi M; Ito I; Yusa N; Kasajima R; Shimizu E; Yamaguchi R; Imoto S; Miyano S; Tanaka Y; Denda T; Ota Y; Tojo A; Kobayashi H
    Front Oncol; 2022; 12():974307. PubMed ID: 36185232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
    Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
    J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical evaluation of BCL-2 expression in acute myeloid leukemia, myeloid sarcoma, and blastic plasmacytoid dendritic cell neoplasm].
    Saika W; Kawahara M; Tashiro H; Teramoto Y; Nagai S; Kumode M; Iwasa M; Asai A; Fujishiro A; Nishimura R; Minamiguchi H; Moritani S; Kito K; Andoh A
    Rinsho Ketsueki; 2020; 61(12):1647-1653. PubMed ID: 33441515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Wang W; Xu J; Khoury JD; Pemmaraju N; Fang H; Miranda RN; Yin CC; Hussein SE; Jia F; Tang Z; Hu S; Konopleva M; Medeiros LJ; Wang SA
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm.
    Fukuchi K; Koyama D; Takada M; Mori H; Hayashi K; Asano N; Sato Y; Fukatsu M; Takano M; Takahashi H; Shirado-Harada K; Kimura S; Yamamoto T; Ikezoe T
    Int J Hematol; 2023 Oct; 118(4):489-493. PubMed ID: 37029861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.
    Alayed K; Patel KP; Konoplev S; Singh RR; Routbort MJ; Reddy N; Pemmaraju N; Zhang L; Shaikh AA; Aladily TN; Jain N; Luthra R; Medeiros LJ; Khoury JD
    Am J Hematol; 2013 Dec; 88(12):1055-61. PubMed ID: 23940084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-discordant expression of myeloid cell nuclear differentiation antigen in blastic plasmacytoid dendritic cell neoplasm.
    Bulterys PL; Saleem A; Brown RA; Novoa RA; Rieger KE; Natkunam Y; Fernandez-Pol S
    Am J Clin Pathol; 2024 Sep; ():. PubMed ID: 39303672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm with Orbital Tumor as the Initial Symptom.
    Li P; Pang N; Li M; Xie J; Wang Y
    Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.